StockWatch
·

Concord Biotech Ltd Q4 FY25 Results

CONCORDBIOQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue429.8876.0%
Total Income439.2769.6%
Expenditure254.1759.2%
PBT185.0986.4%
Net Profit140.3984.9%
OPM44.30%15.13pp
NPM31.96%3.35pp
EPS13.4284.8%
View full financials

Informational and educational content only. Not investment advice.